ロード中...
BAFF and selection of autoreactive B cells
BAFF is a critical survival factor for transitional and mature B cells and is a promising therapeutic target for SLE. A BAFF inhibitor, belimumab, is the first new drug in 50 years to be approved for the treatment of SLE. However, the mechanism of action of this drug is not entirely clear. In this r...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3151317/ https://ncbi.nlm.nih.gov/pubmed/21752714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2011.06.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|